1Queenne Kimverlee C. Landingin, MAN, MSN, 2Belinda A. Ramos, MD, MsPH, FPAMS
1Faculty, College of Nursing, Public Health and Midwifery
2Director, Research Development Office University of La Salette, Inc., Santiago City, Isabela, Philippines, 3311
DOI : https://doi.org/10.47191/ijmra/v8-i02-32Google Scholar Download Pdf
ABSTRACT:
Hypertension (HTN), is one of the leading causes of preventable death worldwide, and remains a public health challenge due to low compliance with therapeutic regimens. This study evaluated the therapeutic regimen compliance amongst hypertensive middle-aged adults in Santiago City, Isabela, Philippines. Using a cross-sectional research design, data were collected from two hundred eighty-five hypertensive individuals aged 45-60 years. A survey instrument, the Hill-Bone Compliance to High Blood Pressure Therapy Scale was used to gather the data of the respondents. The findings of the study discovered that about 92.6% of the respondents unveiled very high compliance with their prescribed treatments for hypertension, while only 7.4% showed high compliance, with none demonstrating low or very low compliance. The statistical investigation has shown that there is no significant association between therapeutic regimen compliance and its demographic features such as age, sex, civil status, or educational accomplishment. Also, the study concluded that compliance in their therapeutic regimen in this population is exceptionally high, and unaffected by demographic factors, and recommends reinforcing current healthcare practices to uphold these outcomes.
KEYWORDS:Hypertension (HTN), Middle-aged adults, Therapeutic Regimen Compliance
REFERENCES1) Boratas, S., & Kilic, H. F. (2018). Evaluation of medication compliance in hypertensive patients and influential factors. Pakistan Journal of Medical Sciences, 34(4), 959.
2) Burnier, M., & Egan, B. M. (2019). Compliance in hypertension: a review of prevalence, risk factors, impact, and management. Circulation research, 124(7), 1124-1140.
3) Gutierrez, M. M., & Sakulbumrungsil, R. C. (2021). Effect of Patient Education Intervention on Medication Compliance and Blood Pressure of Hypertensive Filipino Patients: Systematic Review and Meta-analysis. Philippine Journal of Science, 150(4).
4) Landingin, Q. K. C. Job performance of barangay health workers (BHWS): An assessment.
5) Shrestha, B., Ferdoush, Z., Rabbi, F., & Hossain, A. (2018). Compliance to medications among Nepali hypertensive population: a hospital-based cross-sectional study. Biomed Res Clin Pract, 3(1), 1-4.
6) Son, J. S., Choi, S., Kim, K., Kim, S. M., Choi, D., Lee, G., ... & Park, S. M. (2018). Association of blood pressure classification in Korean young adults according to the 2017 American College of Cardiology/American Heart Association guidelines with subsequent cardiovascular disease events. Jama, 320(17), 1783-1792.
7) Soesanto, E., Ramadlan, I., Setyawati, D., Aisah, S., & Pawestri, P. (2021). Factors affecting medication compliance in hypertension patients: a literature review. Bali Medical Journal, 10(3), 1364-1370.
8) Singh, S., Shankar, R., & Singh, G. P. (2017). Prevalence and Associated Risk Factors of Hypertension: A Cross‐Sectional Study in Urban Varanasi. International journal of hypertension, 2017(1), 5491838.
9) Kurjogi, M. M., Vanti, G. L., & Kaulgud, R. S. (2021). Prevalence of hypertension and its associated risk factors in Dharwad population: A cross-sectional study. Indian heart journal, 73(6), 751-753.
10) Musini, V. M., Tejani, A. M., Bassett, K., Puil, L., & Wright, J. M. (2019). Pharmacotherapy for hypertension in adults 60 years or older. Cochrane Database of Systematic Reviews, (6).
11) Liu, J., Yang, Y., Zhou, J., Liu, T., Zhang, W., Wei, L., & Wu, S. (2020). Prevalence and associated factors of compliance behaviors among middle-aged and older hypertensive patients in China: results from the China Health and Retirement Longitudinal Study. International journal of environmental research and public health, 17(19), 7341.
12) Burnier, M., Polychronopoulou, E., & Wuerzner, G. (2020). Hypertension and drug compliance in the elderly. Frontiers in cardiovascular medicine, 7, 49.
13) Satish, S., Jose, M., & Shabaraya, A. R. Compliance to Antihypertensive Medications and Its Determinants in Hypertensive Patients-A Complete.
14) Zhang, Y., Li, X., Mao, L., Zhang, M., Li, K., Zheng, Y., ... & Jing, M. (2018). Factors affecting medication compliance in community-managed patients with hypertension based on the principal component analysis: evidence from Xinjiang, China. Patient preference and compliance, 803-812.
15) Roka, T., & Ghimire, M. (2019). Medication compliance among hypertensive patients attending a tertiary care hospital in Nepal.
16) Boratas, S., & Kilic, H. F. (2018). Evaluation of medication compliance in hypertensive patients and influential factors. Pakistan Journal of Medical Sciences, 34(4), 959.
17) Naour, O. (2020). Evaluation of Therapeutic Compliance among Moroccan Hypertensive Patients: About 1482 Cases. Jour Clin Med Res, 1(2), 1-9.
18) Pinho, S., Cruz, M., Ferreira, F., Ramalho, A., & Sampaio, R. (2021). Improving medication compliance in hypertensive patients: A scoping review. Preventive Medicine, 146, 106467.
19) Backes, C., Moyano, C., Rimaud, C., Bienvenu, C., & Schneider, M. P. (2021). Digital medication compliance support: could healthcare providers recommend mobile health apps?. Frontiers in medical technology, 2, 616242.
20) Ukoha-Kalu, B. O., Isah, A., Biambo, A. A., Samaila, A., Abubakar, M. M., Kalu, U. A., & Soyiri, I. N. (2023). Effectiveness of educational interventions on hypertensive patients’ self-management behaviours: an umbrella review protocol. BMJ open, 13(8), e073682.
21) Sabaté, E. (2019). "Compliance to Long-Term Therapies: Evidence for Action." World Health Organization.
22) Studer, C. M., Linder, M., & Pazzagli, L. (2023). A global systematic overview of socioeconomic factors associated with antidiabetic medication compliance in individuals with type 2 diabetes. Journal of Health, Population and Nutrition, 42(1), 122.
23) Krousel-Wood, M., et al. (2020). "Compliance to antihypertensive medication: a critical factor in improving blood pressure control and cardiovascular outcomes." Current Hypertension Reports, 22(10), 16.
24) Burnier, M., et al. (2021). "Digital interventions for improving compliance to hypertension treatment." European Heart Journal, 42(11), 1124–1133.
25) Hamrahian, S. M., Maarouf, O. H., & Fülöp, T. (2022). A critical review of medication compliance in hypertension: barriers and facilitators clinicians should consider. Patient preference and compliance, 2749-2757.
26) Abegaz, T. M., Shehab, A., Gebreyohannes, E. A., Bhagavathula, A. S., & Elnour, A. A. (2017). Noncompliance to antihypertensive drugs: a systematic review and meta-analysis. Medicine, 96(4), e5641.
27) Morisky, D. E., et al. (2021). "Predictors of Medication Compliance among Hypertensive Patients in Low-Income Settings." Journal of Human Hypertension, 35(5), 451–459.
28) NCD Risk Factor Collaboration (NCD-RisC). (2022). "Worldwide trends in hypertension prevalence and its management." Lancet Global Health, 9(3), e472-e481.
29) Kim, M. T., Hill, M. N., Bone, L. R., & Levine, D. M. (2000). Development and testing of the hill‐bone compliance to high blood pressure therapy scale. Progress in cardiovascular nursing, 15(3), 90-96.
Volume 08 Issue 02 February 2025
There is an Open Access article, distributed under the term of the Creative Commons Attribution – Non Commercial 4.0 International (CC BY-NC 4.0) (https://creativecommons.org/licenses/by-nc/4.0/), which permits remixing, adapting and building upon the work for non-commercial use, provided the original work is properly cited.
Our Services and Policies
Authors should prepare their manuscripts according to the instructions given in the authors' guidelines. Manuscripts which do not conform to the format and style of the Journal may be returned to the authors for revision or rejected.
The Journal reserves the right to make any further formal changes and language corrections necessary in a manuscript accepted for publication so that it conforms to the formatting requirements of the Journal.
International Journal of Multidisciplinary Research and Analysis will publish 12 monthly online issues per year,IJMRA publishes articles as soon as the final copy-edited version is approved. IJMRA publishes articles and review papers of all subjects area.
Open access is a mechanism by which research outputs are distributed online, Hybrid open access journals, contain a mixture of open access articles and closed access articles.
International Journal of Multidisciplinary Research and Analysis initiate a call for research paper for Volume 08 Issue 02 (February 2025).
PUBLICATION DATES:
1) Last Date of Submission : 25 February 2025 .
2) Article published within a week.
3) Submit Article : editor@ijmra.in or Online
Why with us
1 : IJMRA only accepts original and high quality research and technical papers.
2 : Paper will publish immediately in current issue after registration.
3 : Authors can download their full papers at any time with digital certificate.
The Editors reserve the right to reject papers without sending them out for review.
Authors should prepare their manuscripts according to the instructions given in the authors' guidelines. Manuscripts which do not conform to the format and style of the Journal may be returned to the authors for revision or rejected. The Journal reserves the right to make any further formal changes and language corrections necessary in a manuscript accepted for publication so that it conforms to the formatting requirements of the Journal.